Dental treatment of patients with coagulation factor alterations: An update

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 12, Issue 5, 2007, Pages

  Cerveró, Alba Jover ^a,c   Roda, Rafael Poveda ^b   Bagán, José V ^b   Soriano, Yolanda Jiménez ^b  

^a DDS   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c C/Ribera Alta no 6 ^*  (Montserrat)

Author keywords

Anticoagulant drugs; Bleeding accidents; Coagulation factors; Hemophilia; Hemostasia; Interconsultation; Prevention; Von Willebrand's disease

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BLOOD CLOTTING FACTOR; CAPROAMIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COUMARIN; DESMOPRESSIN; DIAZEPAM; DICOUMAROL; ERYTHROMYCIN; GRISEOFULVIN; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; PARACETAMOL; PENICILLIN G; PROTAMINE SULFATE; PSYCHOTROPIC AGENT; PYRROLE DERIVATIVE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RIFAMPICIN; SULFONAMIDE; TRANEXAMIC ACID; UNCLASSIFIED DRUG; WARFARIN;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD FLOW; BLOOD TRANSFUSION; DENTAL CARE; DRUG CONTRAINDICATION; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; MOUTH HYGIENE; REVIEW; SOFT TISSUE INJURY; SUBSTITUTION THERAPY; TREATMENT PLANNING; VASOCONSTRICTION; VEIN THROMBOSIS; VON WILLEBRAND DISEASE; ORAL SURGERY; PHYSIOLOGY; RISK FACTOR;

BLOOD COAGULATION FACTORS; COAGULATION PROTEIN DISORDERS; HUMANS; ORAL SURGICAL PROCEDURES; RISK FACTORS;

EID: 34848830153     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Quintero-Parada E, Sabater-Recolons MM, Chimenos-Küstner E, López-López J. Hemostasia y tratamiento odontológico. Av Odontoestomatol 2004;20:247-61.
2. Poveda-Roda R. Enfermedades sistémicas y odontología. En: Bagán J V, Scully C, eds. Medicina y Patología Oral. Valencia: Medicina Oral SL; 2006. p. 285-302.
3. Fox SI. Fisiología Humana. Madrid: McGraw-Hill/Interamericana de España S.A.U.; 2002. p. 385-8.
4. Gómez-Moreno G, Cutando-Soriano A, Arana C, Scully C. Hereditary blood coagulation disorders: management and dental treatment. J Dent Res 2005;84:978-85.
5. Little J W, Falace DA, Miller C, Rhodus NL, eds. Tratamiento odontológico del paciente bajo tratamiento médico. Madrid: Harcourt SL; 2001. p. 466-92.
6. Stern R, Karlis V, Kinney L, Glickman R. Using the international normalized ratio to standarize prothrombine time. JADA 1997;128:1121-2.
7. Herman W W, Konzelman JL, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy. JADA 1997;128:327-35.
8. Brown DL. Congenital Bleeding disorders. Curr Probl Pediatr Adolesc Health Care 2005;35:38-62.
9. Schardt-Sacco D. Update on coagulopathies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:559-63.
10. Sans-Sabrafen J, Besses C, Vivens JL, eds. Hematologia clinica. Madrid: Ediciones Harcourt SL; 2001. p. 640-74.
11. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. The Lancet 2003;361:1801-9.
12. Rose LF, Kaye D, eds. Medicina interna en odontología. Barcelona: Salvat editores SA; 1992. p. 439-64.
13. Lavery S. Preimplatation genetic diagnosis: new reproductive options for carriers of haemophilia. Haemophilia 2004;10(Suppl 4):126-32.
14. Villar A, Jiménez-Yuste V, Quintana M, Hernández-Navarro F. The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolitic agents. Haemophilia 2002;8:189-93.
15. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004;351:683-94.
16. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from de United Kingdom Haemophilia Centre Doctors Organisation. Br J Hematol 2006;133:591-605.
17. Pipe SW, Saint-Remy JM, Walsh CE. New high-technology products for the treatment of haemophilia. Haemophilia 2004;10:56-63.
18. Brewer A, Corre ME. Directrices para el tratamiento odontológico de pacientes con trastornos de la coagulación hereditarios. Serie monográfica. El tratamiento de la hemofilia. Montreal, Canadá: Federación Mundial de Hemofilia; 2006.
19. Scully C, Diz-Dios P, Giangrande P, Lee C. Cuidados orales para personas con hemofilia u otras alteraciones hereditarias de la coagulación. Serie monográfica. El tratamiento de la hemofilia. Montreal, Canadá: Federación Mundial de Hemofilia; 2002.
20. Federeci AB. Clinical Diagnosis of von Willebrand disease. Haemophilia 2004;10:169-76.
21. Batlle-Fonrodona J, Noya-Pereira MS, Pérez-Rodríguez A, Lourés-Fraga E, López-Fernández MF. Tratamiento de la enfermedad de von Willebrand y su monitorización. Hematologica 2004;89:10-9.
22. Litchtman MA, Beutler E, Kipps TJ, Williams WJ, eds. Manual Williams de Hematología. Madrid: Marban libros SL; 2005. p. 461-83.
23. Bolton-Maggs, PH Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD et al. The rare coagulation disorders - review with guidelines for managements from the United Kingdom Haemophilia Centre Doctors Organisation. Haemophilia 2004;10:593-628.
24. Collins P. Acquired hemophilia. Semin Hematol 2006; 43:90.
25. Scully C, Wolff A. Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:57-64.
26. Little JW, Miller CS, Henry RG, McInstosh BA. Antitrhombotic agents: implications in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:544-51.
27. Mehra P, Cottrell D, Bestgen SC, Booth DF. Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patients: a review and a proposed nomogram. J Oral Maxillofac Surg 2000;58:198-202.
28. Wahl MJ, Howell J. Altering anticoagulation therapy: a survey of physicians. JADA 1996;127:625-38.
29. Campbell JH, Alvarado F, Murray RA. Anticoagulation and minor oral surgery: should the anticoagulation regime be altered?. J Oral Maxilofac Surg 2000;58:131-5.
30. Vicente-Barrero M, Knezevic M, Tapia-Martin M, Viejo-Llorente A, Orengo-Valverde JC, Garcia-Jimenez F et al. Oral surgery in patients undergoing oral anticoagulant therapy. Med Oral 2002;7:63-70.